Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians
- PMID: 32726824
- DOI: 10.1055/a-1174-1290
Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians
Abstract
Given the aging population, the burden of age-dependent diseases is growing. Despite this, elderly patients are often underrepresented in clinical trials and little data are available on current anticoagulant management and outcomes in this unique population, especially those aged 90 years or older. There is uncertainty, and a fear of "doing harm," that often leads to de-prescription of antithrombotic agents in nonagenarian patients. Decision-making concerning the use of anticoagulant treatment needs to balance the risk of thrombotic events against the risk of major bleeding, especially intracranial hemorrhage. In this perspective, the development of direct oral anticoagulants (DOACs), acting as direct and selective inhibitors of a specific step or enzyme of the coagulation cascade, has dramatically changed oral anticoagulant treatment. In fact, given the lower incidence of intracranial hemorrhage, the favorable overall efficacy and safety, and the lack of routine monitoring, DOACs are the currently recommended anticoagulant agents for the treatment of both atrial fibrillation and venous thromboembolism even in very elderly patients. However, given the limited data available on the management of anticoagulation in nonagenarians, a few unanswered questions remain. In this review, we focused on recent evidence for anticoagulant treatment in atrial fibrillation and venous thromboembolism along with management of anticoagulation-related bleeding in nonagenarians.
Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.JBI Libr Syst Rev. 2012;10(58):4610-4621. doi: 10.11124/jbisrir-2012-429. JBI Libr Syst Rev. 2012. PMID: 27820526
-
Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation.Anatol J Cardiol. 2018 Jan;19(1):67-71. doi: 10.14744/AnatolJCardiol.2017.8256. Anatol J Cardiol. 2018. PMID: 29339702 Free PMC article. Review.
-
Managing the perioperative patient on direct oral anticoagulants.Can J Anaesth. 2017 Jun;64(6):656-672. doi: 10.1007/s12630-017-0868-2. Epub 2017 Apr 20. Can J Anaesth. 2017. PMID: 28429198 Review. English.
-
Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.Lancet Haematol. 2019 Jul;6(7):e359-e365. doi: 10.1016/S2352-3026(19)30086-9. Epub 2019 May 24. Lancet Haematol. 2019. PMID: 31133411
-
Atrial fibrillation decision support tool: Population perspective.Am Heart J. 2017 Dec;194:49-60. doi: 10.1016/j.ahj.2017.08.016. Epub 2017 Aug 23. Am Heart J. 2017. PMID: 29223435 Free PMC article.
LinkOut - more resources
-
Full Text Sources